BridgeBio Pharma Statistics

Total Valuation

BIT:1BBIO has a market cap or net worth of EUR 8.22 billion. The enterprise value is 9.17 billion.

Market Cap	8.22B
Enterprise Value	9.17B

Important Dates

The last earnings date was Friday, August 1, 2025.

Earnings Date	Aug 1, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	191.17M
Shares Outstanding	n/a
Shares Change (YoY)	+7.74%
Shares Change (QoQ)	+0.20%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	150.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	40.94
PB Ratio	-5.43
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-13.87
EV / Sales	45.55
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-16.40

Financial Position

The company has a current ratio of 5.19

Current Ratio	5.19
Quick Ratio	4.74
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-2.83
Interest Coverage	-4.74

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-41.96%
Return on Invested Capital (ROIC)	-108.17%
Return on Capital Employed (ROCE)	-69.58%
Revenue Per Employee	275,816
Profits Per Employee	-908,128
Employee Count	730
Asset Turnover	0.25
Inventory Turnover	n/a

Taxes

In the past 12 months, BIT:1BBIO has paid 2.77 million in taxes.

Income Tax	2.77M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	35.25
200-Day Moving Average	n/a
Relative Strength Index (RSI)	95.47
Average Volume (20 Days)	6

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	6.38

Income Statement

In the last 12 months, BIT:1BBIO had revenue of EUR 200.79 million and -661.12 million in losses. Loss per share was -3.49.

Revenue	200.79M
Gross Profit	193.15M
Operating Income	-535.80M
Pretax Income	-665.67M
Net Income	-661.12M
EBITDA	-531.11M
EBIT	-535.80M
Loss Per Share	-3.49

Full Income Statement

Balance Sheet

The company has 644.49 million in cash and 1.58 billion in debt, giving a net cash position of -937.91 million.

Cash & Cash Equivalents	644.49M
Total Debt	1.58B
Net Cash	-937.91M
Net Cash Per Share	n/a
Equity (Book Value)	-1.51B
Book Value Per Share	-7.96
Working Capital	627.06M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -558.42 million and capital expenditures -662,467, giving a free cash flow of -559.08 million.

Operating Cash Flow	-558.42M
Capital Expenditures	-662,467
Free Cash Flow	-559.08M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	96.19%
Operating Margin	-266.84%
Pretax Margin	-331.52%
Profit Margin	n/a
EBITDA Margin	-264.50%
EBIT Margin	-266.84%
FCF Margin	n/a

Dividends & Yields

BIT:1BBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.74%
Shareholder Yield	n/a
Earnings Yield	-8.04%
FCF Yield	-6.80%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BIT:1BBIO has an Altman Z-Score of -4.14 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.14
Piotroski F-Score	2